Jump to: GLP-1s for type 2 diabetes | GLP-1s for weight loss | Side effects and safety | Take home message GLP-1 receptor agonists (GLP-1s) are a class of medications approved for individuals living with type 2 diabetes and obesity to help lower blood glucose levels (blood sugar) and support weight loss
Understanding Common GLP-1 Side Effects: A Patient's Perspective When Lili Zarghami walked out of her doctors office with a free box of Mounjaro a glucagon-like peptide-1 (GLP-1) agonist from Eli Lilly she felt hopeful that the drug might help her shed extra pounds she had gained related to having polycystic ovary syndrome (PCOS)
Noticeable appetite suppression and early weight changes typically begin around weeks six to eight as the dose increases
After your healthcare provider submits a prior authorization, the insurance company will start its review process
Some vials contained something completely different from what the label said (FDA, 2025)
Also worth noting, Ozempic and Wegovy are essentially the same drug, specifically a GLP-1 known as semaglutide